Clinical trial

Effect of Targeting Left Ventricular Lead Position on the Rate of Response to…

NCT00399594 · University of Calgary, Other · Completed

Key facts

NCT number NCT00399594
Title Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.
Official title Investigating Non-response to Cardiac Resynchronization: Evaluation of Methods to Eliminate Non-response & Target Appropriate Lead Location (INCREMENTAL).
Acronym INCREMENTAL
Lead sponsor University of Calgary, Other
Collaborators Canadian Institutes of Health Research (CIHR) Medtronic Industry Hoffmann-La Roche Cambridge Heart Inc.
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Heart Failure, Congestive, Cardiac Pacing, Artificial, Defibrillators
Intervention type Procedure
Interventions A, B
Enrollment 96
Start date Mar 1, 2011
Primary completion Apr 1, 2014
Completion Nov 1, 2015
First posted Nov 15, 2006
Last update posted Nov 24, 2015
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies